Otonomy to Participate in the H.C. Wainwright BioConnect 2021 Virtual Conference

Rhea-AI Summary

Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical firm focused on innovative therapeutics for neurotology, announced management's participation in a fireside chat at the virtual H.C. Wainwright BioConnect 2021 Conference from January 11-14, 2021. The chat will be accessible on-demand starting January 11 at 6 a.m. EST via the H.C. Wainwright conference portal, and an archived version will be available on the company's Events page. Otonomy specializes in drug delivery technology for ear-related conditions, addressing issues like Ménière’s disease, hearing loss, and tinnitus.

SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that management is scheduled to participate in a fireside chat at the virtual H.C. Wainwright BioConnect 2021 Conference to be held January 11-14, 2021.

The fireside chat will be available on-demand through the H.C. Wainwright conference portal, starting at 6 a.m. EST on Monday, January 11, 2021. An archived webcast will also be accessible through the Events page of the company's website (www.otonomy.com).

About Otonomy

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus. For additional information, please visit www.otonomy.com.

Contacts:

Media Inquiries
Spectrum Science
Chloé-Anne Ramsey
Vice President
404.865.3601
cramsey@spectrumscience.com

Investor Inquiries
Westwicke ICR
Robert H. Uhl
Managing Director
858.356.5932
robert.uhl@westwicke.com

FAQ

When is Otonomy's fireside chat at the H.C. Wainwright BioConnect 2021 Conference?

Otonomy's fireside chat is scheduled for January 11, 2021, at 6 a.m. EST.

How can I access the Otonomy fireside chat?

The fireside chat will be available on-demand through the H.C. Wainwright conference portal.

What is the focus of Otonomy's work?

Otonomy focuses on developing therapeutics for neurotology, including treatments for Ménière’s disease, hearing loss, and tinnitus.

What innovative approach does Otonomy use for drug delivery?

Otonomy utilizes drug delivery technology to achieve sustained drug exposure from a single local administration.

Where can I find more information about Otonomy?

Additional information about Otonomy can be found on their website at www.otonomy.com.